Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry P de Koning

Showing results (21-30 of 171) with videos related to

Pageof 18
Sort By:
Drug Design, Development and Therapy|May 24, 2019
Antileishmanial and antitrypanosomal activity of symmetrical dibenzyl-substituted α,β-unsaturated carbonyl-based compoundsAbdulsalam Am Alkhaldi, Harry P de Koning, Syed Nasir Abbas Bukhari
Molecular Pharmacology|March 20, 2003
A Leishmania major nucleobase transporter responsible for allopurinol uptake is a functional homolog of the Trypanosoma brucei H2 transporterMohammed I Al-Salabi, Lynsey J M Wallace, Harry P De Koning
Drug Development Research|January 29, 2025
Antileishmanial and Antitrypanosomal Trends of Synthetic Tetralone DerivativesAbdulsalam A M Alkhaldi, Harry P de Koning, Syed Nasir Abbas Bukhari
The Journal of Biological Chemistry|April 3, 2016
Trypanosoma brucei Methylthioadenosine Phosphorylase Protects the Parasite from the Antitrypanosomal Effect of Deoxyadenosine: IMPLICATIONS FOR THE PHARMACOLOGY OF ADENOSINE ANTIMETABOLITESMunender Vodnala, Farahnaz Ranjbarian, Anna Pavlova, et al.
Molecular Pharmacology|June 4, 2005
Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1/P2 revisitedFederico Geiser, Alexandra Lüscher, Harry P de Koning, et al.
Analytical Biochemistry|August 30, 2008
Propidium iodide-based methods for monitoring drug action in the kinetoplastidae: comparison with the Alamar Blue assayMatthew K Gould, Xuan Lan Vu, Thomas Seebeck, et al.
Handbook of Experimental Pharmacology|June 23, 2011
Therapeutic potential of phosphodiesterase inhibitors in parasitic diseasesYasmin Shakur, Harry P de Koning, Hengming Ke, et al.
Molecular and Biochemical Parasitology|February 24, 2024
Mapping the transporter-substrate interactions of the Trypanosoma cruzi NB1 nucleobase transporter reveals the basis for its high affinity and selectivity for hypoxanthine and guanine and lack of nucleoside uptakeMustafa M Aldfer, Fabian Hulpia, Serge van Calenbergh, et al.
Molecular and Biochemical Parasitology|January 27, 2018
Trypanosoma brucei bloodstream forms express highly specific and separate transporters for adenine and hypoxanthine; evidence for a new protozoan purine transporter family?Gustavo D Campagnaro, Khalid J Alzahrani, Jane C Munday, et al.
Trends in Parasitology|May 24, 2003
Pentamidine uptake and resistance in pathogenic protozoa: past, present and futurePatrick G Bray, Michael P Barrett, Stephen A Ward, et al.
Pageof 18

Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
Drug Design, Development and Therapy|May 24, 2019
Antileishmanial and antitrypanosomal activity of symmetrical dibenzyl-substituted α,β-unsaturated carbonyl-based compoundsAbdulsalam Am Alkhaldi, Harry P de Koning, Syed Nasir Abbas Bukhari
Molecular Pharmacology|March 20, 2003
A Leishmania major nucleobase transporter responsible for allopurinol uptake is a functional homolog of the Trypanosoma brucei H2 transporterMohammed I Al-Salabi, Lynsey J M Wallace, Harry P De Koning
Drug Development Research|January 29, 2025
Antileishmanial and Antitrypanosomal Trends of Synthetic Tetralone DerivativesAbdulsalam A M Alkhaldi, Harry P de Koning, Syed Nasir Abbas Bukhari
The Journal of Biological Chemistry|April 3, 2016
Trypanosoma brucei Methylthioadenosine Phosphorylase Protects the Parasite from the Antitrypanosomal Effect of Deoxyadenosine: IMPLICATIONS FOR THE PHARMACOLOGY OF ADENOSINE ANTIMETABOLITESMunender Vodnala, Farahnaz Ranjbarian, Anna Pavlova, et al.
Molecular Pharmacology|June 4, 2005
Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1/P2 revisitedFederico Geiser, Alexandra Lüscher, Harry P de Koning, et al.
Analytical Biochemistry|August 30, 2008
Propidium iodide-based methods for monitoring drug action in the kinetoplastidae: comparison with the Alamar Blue assayMatthew K Gould, Xuan Lan Vu, Thomas Seebeck, et al.
Handbook of Experimental Pharmacology|June 23, 2011
Therapeutic potential of phosphodiesterase inhibitors in parasitic diseasesYasmin Shakur, Harry P de Koning, Hengming Ke, et al.
Molecular and Biochemical Parasitology|February 24, 2024
Mapping the transporter-substrate interactions of the Trypanosoma cruzi NB1 nucleobase transporter reveals the basis for its high affinity and selectivity for hypoxanthine and guanine and lack of nucleoside uptakeMustafa M Aldfer, Fabian Hulpia, Serge van Calenbergh, et al.
Molecular and Biochemical Parasitology|January 27, 2018
Trypanosoma brucei bloodstream forms express highly specific and separate transporters for adenine and hypoxanthine; evidence for a new protozoan purine transporter family?Gustavo D Campagnaro, Khalid J Alzahrani, Jane C Munday, et al.
Trends in Parasitology|May 24, 2003
Pentamidine uptake and resistance in pathogenic protozoa: past, present and futurePatrick G Bray, Michael P Barrett, Stephen A Ward, et al.
Pageof 18